Orion Pharma | Page 2 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
June 06, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JUNE 06, 2025

Orion Pharma

Orion Pharma approves 12% cash dividend
Stocks

Orion Pharma approves 12% cash dividend

Also, Orion Infusion Limited approved a 10% cash dividend

Orion Pharma: Unaudited 1st quarterly financial statement
PSI

Orion Pharma: Unaudited 1st quarterly financial statement

Orion Pharma: Un-audited Third Quarterly (Q3) Financial Statements
PSI

Orion Pharma: Un-audited Third Quarterly (Q3) Financial Statements

Orion Pharma’s power subsidiaries seek extension
Corporates

Orion Pharma’s power subsidiaries seek extension

Agreement of Orion’s two power plants to be expired in 2021
Stocks

Agreement of Orion’s two power plants to be expired in 2021

Photo: Collected.
Stocks

Stocks inch up despite low turnover

Orion Pharma in talks for producing Russian Sputnik V vaccine locally
Covid-19 in Bangladesh

Orion Pharma in talks for producing Russian Sputnik V vaccine locally

Orion Pharma wins ICSB Award for corporate governance
Corporates

Orion Pharma wins ICSB Award for corporate governance

Orion Pharma wins SAFA award 2019
Pharma

Orion Pharma wins SAFA award 2019

Representational image. Picture: Collected
Stocks

Three pharma companies ordered to repay intercompany loans

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - DSE
PSI

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - DSE

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - CSE
PSI

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - CSE

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - BSEC
PSI

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - BSEC

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net